Conference Coverage
Conference Coverage
CARMELINA confirms linagliptin’s renal, CV safety, but it’s still third-line for type 2 diabetes
SAN FRANCISCO – The study was unusual among other DPP-4 trials in that almost 60% of the patients were older than 65, and 62.3% had impaired renal...
News
BMI screening trigger for type 2 diabetes is unreliable for at-risk black, Hispanic adults
SAN FRANCISCO – One risk factor should trigger screening in normal weight.
News
Low-fat dairy associated with decreased risk of type 2 diabetes
SAN FRANCISCO – An indicator of healthy living, or a true effect?
Conference Coverage
Type 2 diabetes is particularly devastating in adolescents
SAN FRANCISCO – “These kids have problems you’d expect in their grandparents.” – Dr....
Conference Coverage
SGLT2 inhibitors for type 1 diabetes: Doctors debate the merits
SAN FRANCISCO – Cardiac and renal benefits and the need for more and better options, make these therapies appealing...
Conference Coverage
VOC-sniffing necklace may support early detection of hypoglycemia
SAN FRANCISCO – Same trick as diabetes alert dogs – minus the pup.
Conference Coverage
New findings cast more doubt on ‘fat-but-fit’ theory
Conference Coverage
CAROLINA findings reaffirm linagliptin’s safety, free glimepiride of CV-risk stigma
SAN FRANCISCO – Concerns remain around glimepiride-related weight gain and hypoglycemia.
Conference Coverage
To help patients stay on diabetes regimens: Communicate, educate, and use technology
SAN FRANCISCO – Physicians offer insight and advice on helping patients with diabetes take their medications as directed.
Conference Coverage
Surprise! High-fat dairy may protect against metabolic syndrome
Time to gulp some whole milk? Not yet, but research raises questions.